TEAM
Our board members bring a wealth of expertise from the medical, technological, and business sectors, ensuring that every aspect of your care is supported by leading-edge solutions and compassionate leadership. Their commitment is to not only advance the efficacy of post-operative care through innovative products like the SOMAVAC® but also to ensure that your transition back to normalcy is smooth, supported, and swift.
Elizabeth Hoff, CEO – Board Member
Elizabeth Hoff joined SOMAVAC as CEO in 2024, bringing over 30 years of executive leadership and commercialization experience in MedTech companies such as Guidant, Gore, and Medtronic. Throughout her career, Elizabeth has successfully launched five standard-of-care-changing technologies, including endovascular aortic repair, saphenous vein harvesting, and implantable cardiac monitoring.
Elizabeth holds a Bachelor of Arts in Business and Psychology from Rice University. Her extensive commercial experience and passion for improving patient care align perfectly with SOMAVAC’s mission to revolutionize surgical wound care and prioritize the well-being of breast cancer survivors and all patients. Her dedication to this mission is deeply personal, inspired by her best friend’s journey through breast cancer and reconstruction.
Phil Ryan, COO – Board Member
With over 20 years of experience in MedTech product development, operations, and strategy, Phil Ryan brings a wealth of expertise to his role as COO of SOMAVAC. His leadership has driven growth and innovation across multiple medical device companies, including Olympus ENT. Phil’s deep understanding of product development, manufacturing, and operations, combined with his MS in Engineering Management, ensures SOMAVAC’s mission to revolutionize post-surgical recovery is executed with precision. As COO, Phil plays a key role in supporting the vision of SOMAVAC’s leadership and ensuring operational excellence across the organization.
Bill Martin, Board Member
Bill Martin is a seasoned finance and real estate consultant with extensive experience in leadership roles, in his early career he served as Vice President of First Tennessee Bank N. A. Memphis and later as CFO of Fogelman Properties. Mr. Martin subsequently formed his own Financial Consulting Firm where he has been working with emerging growth companies for the past 25 years. His financial acumen and industry expertise provide key strategic insights to SOMAVAC’s board.
Jean Holloway, Board Member
Jean Holloway brings over 30 years of legal and compliance leadership in the medtech and life sciences industries to her role as a board member for SOMAVAC. She currently serves as Senior Vice President, General Counsel, Chief Compliance Officer, and Secretary at Artivion, Inc., where she leads strategic legal and regulatory initiatives. Her extensive background includes previous roles as Vice President, General Counsel, and Secretary at Bard; Deputy General Counsel at Medtronic, Inc.; Vice President of Litigation at Boston Scientific, Inc.; and Deputy General Counsel at Guidant Corporation. In addition to her corporate experience, Ms. Holloway practiced as a trial lawyer for nearly 15 years with Dorsey & Whitney, Faegre & Benson, and Sidley & Austin. She began her career clerking on the U.S. Court of Appeals for the Seventh Circuit for the Honorable Luther M. Swygert. Ms. Holloway holds a JD/MBA from the University of Chicago and undergraduate degrees in engineering and political science from Yale University.
Scott Moore, Board Member
Scott is a global business executive with deep expertise in medical devices and technology, recognized for driving revenue and EBIT growth through strategic planning, business modeling, and financial analysis. He excels in aligning patient needs with market demands to develop innovative solutions overcoming clinical and economic barriers. Scotthas led global teams, achieving milestones such as growing a diagnostics business from ~$140M to over $600M and transforming patient management strategies for cost savings. Committed to improving patient outcomes and fostering future leaders, he combines strategic vision with operational excellence.
Jane Berz, MSN, RN, FNCBC – Board Chair
Jane Berz brings over 40 years of progressive health care experience in advanced practice oncology nursing, executive oncology administration, and oncology consulting.
Her consulting focus on the patient/breast cancer experience from imaging through treatment into survivorship has defined her work in creating a pathway through all aspects of breast cancer care. She is a Fellow and former board member of the National Consortium of Breast Centers (NCoBC) and has contributed to her community in Chattanooga, TN, through service on non-profit boards in the arts, culture, and health care arena. Jane has been a faculty member of two schools of nursing and continues her love for nursing and teaching through presentations at national conferences and navigating the breast cancer journey for patients.
Jane joined SOMAVAC Medical Solutions, Inc, in 2020 as a clinical advisor and currently serves as Chairperson of the Board. Her expertise and dedication to improving patient outcomes make her an invaluable leader in advancing SOMAVAC’s mission.
She holds a Master of Science in Nursing from the University of Virginia, and a Bachelor of Science in Nursing from the University of Texas at Arlington.
How SOMAVAC® is Revolutionizing Post-Surgical Recovery
Insights from CEO Elizabeth Hoff
SOMAVAC® VISIONARIES
We proudly honor SOMAVAC’s founders.
From left to right: Josh Herwig, PhD; Dr. Stoikes; Dr. Voeller; Esra Roan, PhD.
Their vision and commitment are the foundation of SOMAVAC’s mission to revolutionize post-surgical recovery.